BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

242 related articles for article (PubMed ID: 15706605)

  • 1. Discovery of human antibodies against the C5aR target using phage display technology.
    Huang L; Sato AK; Sachdeva M; Fleming T; Townsend S; Dransfield DT
    J Mol Recognit; 2005; 18(4):327-33. PubMed ID: 15706605
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Anti-C5a receptor antibodies. Characterization of neutralizing antibodies specific for a peptide, C5aR-(9-29), derived from the predicted amino-terminal sequence of the human C5a receptor.
    Morgan EL; Ember JA; Sanderson SD; Scholz W; Buchner R; Ye RD; Hugli TE
    J Immunol; 1993 Jul; 151(1):377-88. PubMed ID: 8326131
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Generation and selection of immunized Fab phage display library against human B cell lymphoma.
    Shen Y; Yang X; Dong N; Xie X; Bai X; Shi Y
    Cell Res; 2007 Jul; 17(7):650-60. PubMed ID: 17621306
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Efficient production of antibodies against a mammalian integral membrane protein by phage display.
    Hötzel I; Chiang V; Diao J; Pantua H; Maun HR; Kapadia SB
    Protein Eng Des Sel; 2011 Sep; 24(9):679-89. PubMed ID: 21810920
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Screening and evaluation of human single-chain fragment variable antibody against hepatitis B virus surface antigen.
    Zhang JL; Gou JJ; Zhang ZY; Jing YX; Zhang L; Guo R; Yan P; Cheng NL; Niu B; Xie J
    Hepatobiliary Pancreat Dis Int; 2006 May; 5(2):237-41. PubMed ID: 16698583
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Selection of full-length IgGs by tandem display on filamentous phage particles and Escherichia coli fluorescence-activated cell sorting screening.
    Mazor Y; Van Blarcom T; Carroll S; Georgiou G
    FEBS J; 2010 May; 277(10):2291-303. PubMed ID: 20423457
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Isolation, characterization, and recovery of small peptide phage display epitopes selected against viable malignant glioma cells.
    Spear MA; Breakefield XO; Beltzer J; Schuback D; Weissleder R; Pardo FS; Ladner R
    Cancer Gene Ther; 2001 Jul; 8(7):506-11. PubMed ID: 11498772
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Probing the human receptor for C5a anaphylatoxin with site-directed antibodies. Identification of a potential ligand binding site on the NH2-terminal domain.
    Oppermann M; Raedt U; Hebell T; Schmidt B; Zimmermann B; Götze O
    J Immunol; 1993 Oct; 151(7):3785-94. PubMed ID: 8376805
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Discovery of human antibodies to cell surface antigens by capture lift screening of phage-expressed antibody libraries.
    Watkins JD; Beuerlein G; Wu H; McFadden PR; Pancook JD; Huse WD
    Anal Biochem; 1998 Feb; 256(2):169-77. PubMed ID: 9473274
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Cloning of human monoclonal Fab fragments against HIV-1 gp120 peptide binding chemokine receptor from phage Fab antibody library].
    Shen H; Mao P; Hong S; Hou J; Yang J
    Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi; 2002 Dec; 16(4):357-60. PubMed ID: 12665905
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Molecular characterization of the circulating anti-HIV-1 gp120-specific B cell repertoire using antibody phage display libraries generated from pre-selected HIV-1 gp120 binding PBLs.
    Koefoed K; Farnaes L; Wang M; Svejgaard A; Burton DR; Ditzel HJ
    J Immunol Methods; 2005 Feb; 297(1-2):187-201. PubMed ID: 15777942
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Rapid generation of functional human IgG antibodies derived from Fab-on-phage display libraries.
    Jostock T; Vanhove M; Brepoels E; Van Gool R; Daukandt M; Wehnert A; Van Hegelsom R; Dransfield D; Sexton D; Devlin M; Ley A; Hoogenboom H; Müllberg J
    J Immunol Methods; 2004 Jun; 289(1-2):65-80. PubMed ID: 15251413
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Rapid kinetic-based screening of human Fab fragments.
    Steukers M; Schaus JM; van Gool R; Hoyoux A; Richalet P; Sexton DJ; Nixon AE; Vanhove M
    J Immunol Methods; 2006 Mar; 310(1-2):126-35. PubMed ID: 16481004
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Isolation of human prostate cancer cell reactive antibodies using phage display technology.
    Popkov M; Rader C; Barbas CF
    J Immunol Methods; 2004 Aug; 291(1-2):137-51. PubMed ID: 15345312
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Screening isolates from antibody phage-display libraries.
    Buckler DR; Park A; Viswanathan M; Hoet RM; Ladner RC
    Drug Discov Today; 2008 Apr; 13(7-8):318-24. PubMed ID: 18405844
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Generation of human recombinant antibody Fab fragment and its IgG to adeno-associated virus type II from phage display library].
    Yao LS; Wang T; Liang MF; Yuan ZH; Ji Y; Wu XB; Li DX
    Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi; 2003 Sep; 17(3):240-3. PubMed ID: 15340567
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The human combinatorial antibody library HuCAL GOLD combines diversification of all six CDRs according to the natural immune system with a novel display method for efficient selection of high-affinity antibodies.
    Rothe C; Urlinger S; Löhning C; Prassler J; Stark Y; Jäger U; Hubner B; Bardroff M; Pradel I; Boss M; Bittlingmaier R; Bataa T; Frisch C; Brocks B; Honegger A; Urban M
    J Mol Biol; 2008 Feb; 376(4):1182-200. PubMed ID: 18191144
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Isolation and characterization of phage-displayed single chain antibodies recognizing nonreducing terminal mannose residues. 1. A new strategy for generation of anti-carbohydrate antibodies.
    Sakai K; Shimizu Y; Chiba T; Matsumoto-Takasaki A; Kusada Y; Zhang W; Nakata M; Kojima N; Toma K; Takayanagi A; Shimizu N; Fujita-Yamaguchi Y
    Biochemistry; 2007 Jan; 46(1):253-62. PubMed ID: 17198396
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A combination of in vitro techniques for efficient discovery of functional monoclonal antibodies against human CXC chemokine receptor-2 (CXCR2).
    Boshuizen RS; Marsden C; Turkstra J; Rossant CJ; Slootstra J; Copley C; Schwamborn K
    MAbs; 2014; 6(6):1415-24. PubMed ID: 25484047
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Isolation of neutralizing anti-C5a monoclonal antibodies from a filamentous phage monovalent Fab display library.
    Ames RS; Tornetta MA; Jones CS; Tsui P
    J Immunol; 1994 May; 152(9):4572-81. PubMed ID: 8157971
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.